Wednesday, 12 December 2018

Effect of oral alfacalcidol on clinical outcomes in patients without secondary hyperparathyroidism

Treatment with active vitamin D did not decrease cardiovascular events in kidney patients undergoing hemodialysis, according to a research group in Japan. They have reported their research results in the December 11 issue of JAMA.

from Health News - Health, Health Technology https://ift.tt/2QHaozd
via IFTTT

No comments:

Post a Comment